体脂量介导非糖尿病老年人胰岛素抵抗与功能衰退及死亡率的关联
基于西班牙Toledo健康老龄化队列的纵向研究,纳入1114名65岁以上非糖尿病社区老年人,评估胰岛素抵抗(HOMA-IR)与功能衰退及死亡率的关联,并分析体成分的中介作用。结果显示HOMA-IR升高增加功能衰退风险,且该关联主要由总脂肪量和躯干脂肪量介导;HOMA-IR与死亡风险呈负相关,该关联也部分由脂肪量介导。瘦体重调整不影响任何关联。
要点
- HOMA-IR每增加1个对数单位,功能衰退风险增加41%(OR 1.41,95%CI 1.09-1.83)。
- 总脂肪量和躯干脂肪量分别解释功能衰退关联的62.92%和91.49%。
- HOMA-IR与死亡风险负相关(HR 0.66,95%CI 0.49-0.87),脂肪量部分介导该关联。
核心结论
- 体脂肪量尤其是躯干脂肪量介导了非糖尿病老年人胰岛素抵抗与功能衰退的关联,并在较小程度上介导了与死亡风险降低的关联。
研究设计与样本
- 纵向人群队列研究,来自西班牙Toledo健康老龄化队列,纳入1114名65岁以上非糖尿病社区老年人(平均年龄74.5岁,女性56.10%),基线数据完整。
- 功能评估随访期间仅914名参与者完成全面评估,功能衰退定义为FTS-5评分下降2.5分,中位随访2.99年;死亡数据来自西班牙国家死亡索引,中位随访6.31年。
- 胰岛素抵抗用基线HOMA-IR评估,体成分用双能X线吸收法测定,多变量回归模型基本调整年龄、性别、Charlson指数和药物数量。
主要发现
- 进一步调整总脂肪量后关联消失(OR 1.14,95%CI 0.86-1.50),总脂肪量解释62.92%的关联;调整躯干脂肪量后关联消失(OR 1.03,95%CI 0.77-1.37),解释91.49%的关联。
- 瘦体重调整未改变任何关联。
关键数值与推荐
- 功能衰退定义为FTS-5评分下降2.5分。
- 胰岛素抵抗用HOMA-IR评估。
- 体成分用双能X线吸收法测定总脂肪量、躯干脂肪量和瘦体重。
临床怎么用
- 在非糖尿病老年人群中评估胰岛素抵抗时,应结合体成分尤其是躯干脂肪量来解读功能衰退风险。
- 体脂量可能解释胰岛素抵抗与功能衰退及死亡率关联的大部分,临床干预可关注体脂分布。
局限性
- 功能评估随访仅914名参与者完成全面评估,存在样本减少。
- 研究为观察性队列,不能确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the potential role of body composition in the association of insulin resistance (IR) with functional decline and mortality in nondiabetic older persons. DESIGN: Longitudinal population-based cohort of community-dwelling people from Toledo, Spain, aged 65 years or older. SETTING AND PARTICIPANTS: A total of 1114 nondiabetic persons from the Toledo Study of Healthy Aging cohort (mean age: 74.5, 56.10% female) with complete data at baseline were included. Only 914 participants had fully assessment of functional evaluation during the follow-up period. METHODS: IR was determined by the homeostasis model assessment index (HOMA-IR) at baseline while frailty was assessed by the Frailty Trait Scale-5 (FTS-5) at baseline and after 2.99 years' median follow-up period. A total of 319 participants experienced functional decline (2.5-point reduction in the FTS-5 score). A total of 143 deaths were recorded (6.31 years median follow-up) from the Spanish National Death Index. Body compositions were determined using dual-energy x-ray absorptiometry. Multivariate regression models analyzed the effect of HOMA-IR on outcomes, with age, sex, Charlson index, and number of medications included in the basic adjustment model. RESULTS: A 1-logaritmic unit increment in HOMA-IR increased the risk of functional decline after basic adjustment [odds ratio (95% confidence interval): 1.41 (1.09-1.83), P = .009]. This significant association was lost when further adjusted for total fat mass [1.14 (0.86-1.50)] and trunk fat mass [1.03 (0.77-1.37)], which accounted for 62.92% and 91.49% of the association. HOMA-IR was inversely associated with mortality risk [hazard ratio 0.66 (0.49-0.87), P = .0037], an association lost after adjustment for total fat mass [0.74 (0.55-1.01)] and trunk fat mass [0.80 (0.58-1.09)], accounting for 29.05% and 45.78% of the association. Adjustment by lean mass did not modify any of the associations. CONCLUSIONS AND IMPLICATIONS: Body fat mass, especially in the trunk region, mediates the association of IR with functional decline and to a lesser extent with reduced risk of mortality in nondiabetic older subjects.
引用
- El Assar M, Carnicero JA, Angulo J, et al. Fat Mass Accounts for Insulin Resistance Impact on Functional Decline and Mortality in Nondiabetic Older Adults. J Am Med Dir Assoc. 2023. PMID: 37898163. doi:10.1016/j.jamda.2023.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。